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Loss of Calcineurin Aa Alters Keratinocyte Survival
and Differentiation
Juan A. Pena1, Jacqueline L. Losi-Sasaki2 and Jennifer L. Gooch1,3
Calcineurin is a serine/threonine phosphatase that is inhibited by the immunosuppressive drugs cyclosporine
and FK506. Although calcineurin has been extensively studied in immune cells, less is known about calcineurin
in other systems. There are two primary isoforms of the catalytic subunit of calcineurin, and mice have been
created that lack either the a isoform (calcineurin A (CnA)a/) or the b isoform (CnAb/). In this study, we
examined the epidermis of CnAa/ mice at birth and 4 weeks of age. Histological analyses revealed an
attenuation of cells in the stratum spinosum of CnAa/ mice. There was no significant difference in
proliferation in the epidermis of CnAa/ sections, but TUNEL assay revealed increased cell death in the supra-
basal layers. Interestingly, the calcineurin substrate nuclear factor of activated T cells (NFATc) was highly
expressed in the nucleus of basal epidermal cells in wild-type (WT) mice but was cytoplasmic in CnAa/ mice,
consistent with a loss of calcineurin activity. Moreover, NFATc activity was decreased in the epidermis of null
mice compared with that in WT littermates. Finally, immunohistochemical staining revealed supra-basal
expression of keratin 14 and decreased expression of differentiation-associated keratin 10 and involucrin. These
findings suggest that calcineurin Aa activity is required for the normal differentiation and survival of epidermal
cells.
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INTRODUCTION
Calcineurin is a serine/threonine protein phosphatase that is
essential for coordinating calcium signaling with nuclear
action. It was initially localized to neural tissue but has since
been described in other tissues, most notably the immune
system, in which inhibition of calcineurin by cyclosporine
leads to a loss of T-cell function (Rusnak and Mertz, 2000).
Calcineurin modulates the transcription factor nuclear factor
of activated T cells (NFATc), which is cytoplasmic and
inactive when phosphorylated. Calcium-dependent depho-
sphorylation by calcineurin leads to nuclear translocation
and modification of target genes including IL-2 (Liu et al.,
1991; Rao et al., 1997).
There are three isoforms of the catalytic subunit of
calcineurin, namely a, b, and g. The a and b isoforms are
found in most mammalian tissues, whereas g is primarily
expressed in the testes and brain (Rusnak and Mertz, 2000).
Mice lacking the a and b isoforms have been created and
have been reported to have distinct phenotypes. For example,
calcineurin A (CnA)b/ mice are viable, fertile, and overtly
normal well into adulthood, but have abnormal immune
systems (Bueno et al., 2002). In contrast, CnAa/ mice are
significantly smaller, infertile, and typically only live a few
weeks (Zhang et al., 1996; Zhuo et al., 1999; Gooch et al.,
2004). Their immune systems, however, are only mildly
affected and the mice can still be immunosuppressed by
cyclosporine (Zhang et al., 1996). Moreover, CnAa/ mice
have defects in renal development and function including
increased fibrosis and upregulation of TGFb (Gooch et al.,
2007). Cyclosporine and FK506 are inhibitors of calcineurin
that have been used to treat a number of disorders
involving multiple organ systems. They have revolutionized
transplant medicine and have also been useful in the
treatment of many skin disorders (Lim et al., 1996). The
effects of cyclosporine on dermatological conditions are
typically attributed to suppression of epidermal immune
cells. However, a direct role for calcineurin in the epidermis
cannot be excluded.
For example, calcineurin activity has been recently
measured directly in cells that populate skin, including
melanocytes and keratinocytes (Smit et al., 2008). Moreover,
inhibition of calcineurin has been shown to block prolifera-
tion of cultured keratinocytes (Fisher et al., 1988; Nickoloff
et al., 1988). Others have noted that suppression of
calcineurin inhibits p21 expression and downregulates
keratinocyte differentiation (Santini et al., 2001). These
results bear some similarities to findings reported by our
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laboratory. We have previously shown changes in prolifera-
tion and expression of the cyclin-dependent kinase inhibitor
p27 with loss of CnAa in the kidney (Gooch et al., 2004). This
suggests that the a isoform of calcineurin may be involved in
pathways that are also important for normal differentiation
and/or cell cycle control of epidermal cells. More impor-
tantly, other authors have connected the Notch signaling
cascade with the calcineurin/NFAT pathway (Mammucari
et al., 2005). This finding is significant, as Notch signaling has
been shown to be a key player in the progression of
keratinocytes from basal to spinosum and granular layers
(Moriyama et al., 2008). Therefore, we examined the skin of
newborn and 4-week-old CnAa/ mice and wild-type (WT)
littermates, and reported that CnAa plays a direct role in the
differentiation and survival of keratinocytes.
RESULTS
Mice lacking CnAa show skin abnormalities
To examine a potential role for calcineurin in the epidermis,
CnAa/ and WT epidermal sections were collected and
stained using H&E, and examined by light microscopy. At
birth, WT epidermal sections consisted of a well-organized
basal-cell layer, two- to three-cell thickness of stratum
spinosum, and normal appearing granular and corneum
layers (Figure 1a). In contrast, the stratum spinosum of
newborn CnAa/mice seemed markedly attenuated (Arrow-
head, Figure 1b). Although the granular layer seems
unremarkable, there is a thickening of the corneum and a
greater number of keratinocytes seem to be in the process of
‘‘sloughing-off’’ (Figure 1b). At 4 weeks of age, despite
normal follicular eruption, a similar attenuation of the
epidermis is observed in CnAa/ mice (Figures 1c and d).
Skin elasticity was observed by comparing the response of 4-
week-old CnAa/ and WT littermates to deformation of the
nape by pinching. Results were noted at the time WT skin
returned to a normal appearance. Deformation persisted
longer in CnAa/ than was observed in WT mice (Figure 1e).
In addition, epidermal sloughing in arm and neck folds was
observed in CnAa/ pups before follicular eruption (data not
shown). Sections from CnAb/ samples were consistent with
the normal appearance observed in WT samples, suggesting
that the a isoform plays a predominant role in epidermis
(Supplementary Figure S1).
Loss of CnAa increases apoptosis and results in alterations in
keratin expression
Changes in CnAa/ epidermal sections were further
characterized. To begin, cell proliferation within the epider-
mis of WT and CnAa/ mice was determined by identifying
cells that express the DNA replication protein proliferating
cell nuclear antigen. Similar to the WT, the majority of
proliferating cells were identified in the stratum basale and in
the developing follicles of CnAa/ sections (Figures 2a
and b). Quantitation of results from WT and CnAa/ mice
showed that there were no significant differences in
proliferation with loss of CnAa (Figure 2e). In addition to
proliferation, cell death in the epidermis of WT and CnAa/
sections was examined by TUNEL stain. This technique
revealed an increase in cells undergoing cell death in the
supra-basal layers of CnAa/ sections compared with that in
WT (Figure 2c and d), consistent with attenuation of the
stratum spinosum layer observed by H&E stain (Figure 1b).
Quantitation of results from WT and CnAa KO mice revealed
a significant increase in cell death in the stratum spinosum
with loss of CnAa (Figure 2f).
Calcineurin activity in vivo can be indirectly followed by
subcellular localization of target proteins including NFATc,
which translocate to the nucleus on dephosphorylation by
calcineurin. Therefore, subcellular localization of NFATc was
examined by immunofluorescence in WT and CnAa/
epidermal sections. Figure 3a shows that NFATc is readily
detectable in basal epidermal cells and that it is predomi-
nantly nuclear (asterisk, Figure 3a). In contrast, NFATc
seemed to be excluded from the nucleus in CnAa/ mice
(arrow, Figure 3b). Cytoplasmic localization suggests a loss of
NFATc transcriptional activity. To examine NFATc activity,
Figure 1. Changes in the skin with loss of CnAa. Epidermal sections from newborn WT (a) and CnAa/ (b) mice were obtained from the nape of the neck,
paraffin-embedded, stained with H&E, and examined by light microscopy. Arrowhead indicates attenuation of the stratum spinosum. Results shown are
representative of at least five mice per genotype. Epidermal sections were then likewise obtained from 4-week-old WT (c) and CnAa/ (d) mice. (e) The nape of
WT and CnAa/ mice was gently pinched for 5 seconds and then a return to normal appearance was observed. Deformation of CnAa/ mice (left) was still
apparent by the time WT mice (right) had returned to normal. Data shown is typical result of multiple trials using five mice per genotype. Bar¼ 20 mm.
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skin samples were obtained from WT and CnAa/ mice that
also express an NFATc-driven luciferase reporter construct
(Parsons et al., 2003). Epidermal samples were minced,
incubated in lysis buffer, and then luciferase expression was
quantified by luminescence. Figure 3c shows that there is a
significant decrease of 74%±2.2 (SEM) in luciferase
activity in CnAa/ epidermal sections compared with that
in wild type.
Finally, we examined expression of proteins that are
specific for the basal, spinosum, and granular layers. In WT
sections, there is robust expression of keratin 14 in the basal
layer (Figure 3d), whereas the fully differentiated supra-basal
layers express keratin 10 (Figure 3e) and the granular layer
expresses involucrin (Figure 3f). This arrangement was not
found in CnAa/ mice. Instead, supra-basal layers continue
to express keratin 14 (Figure 3g, arrowhead) and show
attenuation of keratin 10 (Figure 3h, arrow) and involucrin
(Figure 3i). These findings suggest that loss of CnAa leads to
impaired differentiation of epidermal keratinocytes.
DISCUSSION
In this study, we have shown that loss of the a isoform of
calcineurin leads to abnormal differentiation of keratinocytes
and an altered epidermis. Grossly, the skin of CnAa/ mice
is mildly abnormal and characterized by increased ‘‘laxness’’
and decreased elasticity. Histologically, the normal
architecture found in WT dermis is altered. There is an
attenuation of the supra-basal layers that seems to be due to
increased apoptosis and/or premature differentiation of
keratinocyte. Moreover, the deletion of calcineurin leads to
loss of nuclear NFATc localization in basal cells and
decreased NFATc activity in the epidermis. Finally,
loss of calcineurin is associated with defects in the
differentiation of keratinocytes. Supra-basal layers retain
expression of keratin 14, and express less keratin 10 and
involucrin. Taken together, these findings support a role for
the a isoform of calcineurin in normal differentiation and
survival of keratinocytes. The absence of similar changes in
CnAb/ mice suggests that keratinocyte survival and
differentiation may be additional examples of isoform-
specific actions of CnAa.
Although previous studies have found that loss of
calcineurin activity in the epidermis alters follicular cells
and hair growth (Al-Daraji et al., 2002; Gafter-Gvili et al.,
2003), it is interesting to note that CnAa/ mice have no
observable hair growth or pigmentation defects through 4
weeks of age. This may be due, however, to a lack of data
from older animals due to the early death of null mice.
Despite the limitations of the model, CnAa/mice may offer
insight not only into the skin changes associated with
calcineurin inhibitors, but also dermatological disorders such
as psoriasis.
The relationship between calcineurin and immunomodu-
lation has been well established, and calcineurin inhibition
has found a central role in the treatment of dermatological
pathologies. The therapeutic effects of these drugs have been
attributed to the immunomodulatory effect of calcineurin
inhibitors. However, there is evidence that other mechanisms
are in play. A recent study in this journal measured
calcineurin activity in the skin, and successfully showed
cyclosporine-mediated calcineurin inhibition in keratino-
cytes and melanocytes (Smit et al., 2008). Cyclosporine has
been shown in vitro to alter proliferation of keratinocytes
(Fisher et al., 1988; Nickoloff et al., 1988), and multiple
reports have linked calcium and calcium-dependent signal-
ing mechanisms to keratinocyte differentiation (Yuspa et al.,
1989; Santini et al., 2001; Mammucari et al., 2005;
Sakaguchi et al., 2005). More specifically, calcineurin and
NFATc are expressed in the epidermis (Al-Daraji et al., 2002),
and activation of the pathway is linked to control of cell cycle
proteins including p21 (Santini et al., 2001; Mammucari
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Figure 2. Changes in cell cycle with loss of CnAa/. Proliferating cells
within the epidermis were identified in newborn WT (a) and CnAa/ (b)
epidermal sections by expression of the DNA replication protein proliferating
cell nuclear antigen (PCNA) after immunohistochemistry using a specific
antibody. Results are typical for at least three mice per genotype. Bar¼ 50 mm.
Cell death within the epidermis was determined in wild-type (c) and CnAa/
mice (d) by TUNEL assay. Data presented are representative of results from at
least three different mice per group. Bar¼ 50 mm. (e) PCNA expression as
shown in panels a and b was semi-quantitated and graphed. Positive cells in
at least three separate frames (20–40 cells per frame) were scored by a blinded
reviewer for each animal. Data shown are the mean±SEM of at least three
different mice per genotype. No significant difference in cell proliferation was
noted between the WT and CnAa/ sections. (f) Cell death indicated by
TUNEL assay was semi-quantitated and graphed. Positive cells in at least three
separate frames (20–40 cells per frame) were scored by a blinded reviewer
for each animal. Results from at least three different animals were
semi-quantitated and graphed. Data shown are the mean±SEM. There
were significantly more cells undergoing apoptosis in CnAa/ sections than
in WT (**Po0.01).
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et al., 2005). Finally, calcineurin has been connected to the
Notch signaling cascade (Mammucari et al., 2005), a
significant finding given Notch’s central role in coordinating
epidermal development (Moriyama et al., 2008). Moreover,
the Notch cascade is also important in certain disease
processes, including psoriasis (Thelu, 2002). Our data
showing specific changes in keratinocyte differentiation and
survival with loss of CnAa provides yet more evidence that
calcineurin is an important component of the epidermis. The
phenotype we report in the CnAa/ mouse model is
particularly significant in light of previous findings that the
immune system of null mice develop normally (Zhang et al.,
1996) and that mice with CnAa/ immune systems can still
be immunosuppressed with cyclosporine (Zhang et al.,
1996). Therefore, a role for calcineurin in epidermal differ-
entiation and survival may be independent of its action in the
immune system.
Further, psoriasis is a common skin disorder that is caused
by an immune reaction including inflammatory cytokine
production and characterized by hyper-proliferation of the
stratum spinosum (Chamian and Krueger, 2004). The
immunological angle of the disease process has been well
established, and is supported by the therapeutic benefits of
cyclosporine. However, it is possible that the benefits of
cyclosporine treatment may also be due to a direct effect on
the cellular machinery of keratinocytes. Interestingly, Notch
genes seem to play a role in psoriasis, as these have been
noted to be downregulated in psoriatic plaques (Thelu, 2002).
We have shown here that loss of CnAa leads to a phenotype
that is the opposite of psoriasis—increased cell death in the
stratum spinosum and fragile skin. Furthermore, the ther-
apeutic success of cyclosporine to heal psoriatic plaques may
also be due to its ability to alter differentiation of
keratinocytes and survival of supra-basal cells.
We have presented data, to our knowledge previously
unreported, that supports the hypothesis that calcineurin is
required for the differentiation and survival of keratinocytes.
CnAa/ mice are characterized by increased skin laxness,
with epidermal sections that show an attenuation of the
stratum spinosum and decreased NFATc activity. Moreover,
CnAa/ stratum spinosum keratinocytes fail to differentiate
normally and undergo cell death. These findings provide
further evidence of the role of calcineurin keratinocytes
differentiation and survival.
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Figure 3. NFATc activity is lost and differentiation is altered with loss of CnAa. Cellular localization of the calcineurin substrate NFATc was determined
by immunofluorescence in epidermal sections from 4-week-old wild-type (a) and CnAa/ (b) mice using an antibody that recognizes all calcineurin-regulated
NFATc proteins. Protein expression was visualized using a Cy3-conjugated secondary antibody. Bar¼ 20mm. Data shown are representative of at least
three different mice per genotype. Asterisk indicates nuclear localization in WT and arrowhead indicates cytoplasmic localization in CnAa/ (b). (c) NFATc
activity was examined in dermal/epidermal skin samples from 4-week-old wild-type and CnAa/ mice that constitutively express an NFATc-responsive
luciferase promoter construct. Samples were obtained from mice positive for the reporter transgene, and luciferase activity was measured. Results were
compared with background luminescence values obtained from samples from littermate mice lacking the reporter construct (control). Data shown are the
mean±SEM of three mice per group. Next, expression of the epidermal markers were examined in 4-week-old WT mice including K14 (d), K10 (e), and
involucrin (f) by immunofluorescence. Protein expression was visualized using FITC-conjugated or Cy3-conjugated secondary antibodies. Data shown are
representative of at least three mice per group. Finally, the same markers were examined in epidermal sections from 4-week-old CnAa/ mice (g–i). The
arrowhead highlights supra-basal expression of K14 and the arrow indicates lack of expected K10 expression in supra-basal layers. Data shown are
representative of at least three mice per group.
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MATERIALS AND METHODS
Materials
Antibodies that recognize all calcium-dependent isoforms of NFAT
(c1-c4), and keratins 10 and 14 were obtained from Santa Cruz
(Santa Cruz, CA); anti-proliferating cell nuclear antigen antibody was
obtained from Dako (Glostrup, Denmark).
Animal models
CnAa/mice were created by J. Seidman (Howard Hughes Medical
Institute, Harvard Medical School, Boston, MA) as previously
described (Zhang et al., 1996) and kindly provided to our laboratory.
Animals were maintained and bred in the animal facility at the
Atlanta Veteran Affairs Medical Center, Decatur, GA, in accordance
with Institutional Animals Care and Use Committee standards.
Genotypes of offspring from heterozygous breeding pairs were
determined by PCR reaction using the following primers: 50-
GGCAGGAGAGTAAATTCTTGC, 30-GTGGAATTCTCTGGAGA-
CAAACCACC, and neo-TCTTGATTCCCACTTTGTGGTTCTA. CnAb
mice were created by J. Molkentin (Cincinnati Children’s Hospital,
Cincinnati, OH) and were previously described (Parsons et al.,
2003). CnAa/ mice were created on a mixed genetic background.
Therefore, all the experiments were carried out with WT and, where
indicated, heterozygous littermates.
NFATc-driven luciferase reporter mice
Mice expressing an NFATc-responsive luciferase reporter plasmid
(NFATc-luc) were created by Jeffrey Molkentin (Cincinnati Chil-
dren’s Hospital, Cincinnati, OH) and were previously described
(Parsons et al., 2003). Mice expressing one copy of the NFATc-
luciferase plasmid were bred with CnAaþ / mice to produce WT
and CnAa/ mice that express the reporter plasmid as well as
littermates that are negative for NFATc-luc, which serve as negative
controls. Skin samples including both dermis and epidermis
were harvested from mice, finely minced, and then lysed in 1ml of
passive lysis buffer per milligrams of tissue. Luciferase expression
was then measured according to the manufacturer’s instructions
(Promega, Madison,WI) and quantified using a luminometer. As an inter-
nal control for background luminescence, luminescence values were
also obtained from littermate mice that do not express the construct.
Histology
Epidermal sections from newborn mice were immersed in formalin
or quickly frozen in liquid nitrogen for further analyses. Routine
histology was on 4-mm thick sections from each genotype stained
with H&E. In addition, epidermal sections from three to five animals
of each genotype were analyzed using TUNEL assay to identify cells
undergoing cell death.
Immunohistochemistry. It was performed as previously described
(Gooch et al., 2004). Sections were counter-stained with hemotox-
ylin, coverslips were mounted with Permount (Sigma, St Louis, MO),
and sections were viewed by brightfield microscopy.
Immunofluorescence. Frozen sections of 6-mm thickness were
mounted on glass slides and then fixed in acetone. Sections were
rehydrated in PBS (phosphate-buffered saline)/0.1%BSA before
blocking with the appropriate IgG. Primary antibodies were added
at concentrations between 10 and 20 mgml1 for 1 h at room
temperature. After incubation with primary antibodies, sections were
washed thrice for 5minutes each time in PBS/0.1%BSA. Fluores-
cence-conjugated secondary antibodies were added at dilutions of
1:100 for 45minutes at room temperature followed by washing in
PBS/0.1%BSA. Sections were mounted with Crystal Mount (Dako)
and allowed to dry before viewing with fluorescence microscopy.
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